Innoviva (INVA) EBITDA (2010 - 2026)

Innoviva (INVA) has 17 years of EBITDA data on file, last reported at $38.2 million in Q1 2026.

• Quarterly EBITDA fell 7.9% year-over-year to $38.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.8 million (down 5.48% YoY) and the FY2025 annual result came in at $163.7 million, down 1.87% from the prior year.
• EBITDA advanced to $38.2 million in Q1 2026, from -$13.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $131.3 million in Q3 2023 to a low of -$31.3 million in Q2 2023.
• A 5-year average of $28.5 million and a median of -$6.6 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA tumbled 124.9% — and 2025, when it surged 346.51%.
• Tracing INVA's EBITDA over 5 years: stood at -$10.3 million in 2022, then jumped by 36.31% to -$6.6 million in 2023, then sank by 60.22% to -$10.5 million in 2024, then plunged by 31.16% to -$13.8 million in 2025, then jumped by 376.02% to $38.2 million in 2026.
• The last three EBITDA figures came in at $38.2 million (Q1 2026), -$13.8 million (Q4 2025), and $124.8 million (Q3 2025), per Business Quant data.